Table of contents

1. Introduction

1.1 Market Definition

1.2 Scope (Inclusion and Exclusions)

1.3 Research Assumptions

2. Executive Summary

2.1 Market Overview

2.2 Regional Synopsis

2.3 Competitive Summary

3. Research Methodology

3.1 Top-Down Approach

3.2 Bottom-up Approach

3.3. Data Validation

3.4 Primary Interviews

4. Market Dynamics Impact Analysis

4.1 Market Driving Factors Analysis

4.1.2 Drivers

4.1.2 Restraints

4.1.3 Opportunities

4.1.4 Challenges

4.2 PESTLE Analysis

4.3 Porter’s Five Forces Model

5. Statistical Insights and Trends Reporting

5.1 Incidence and Prevalence of End-Stage Heart Failure (2023), by Region

5.2 Waitlist and Transplant Gap Statistics (2023)

5.3 Healthcare Spending on Mechanical Circulatory Support Devices (2023), by Payer Type (Government, Commercial, Private, Out-of-Pocket)

5.4 Technological Adoption & R&D Pipeline (2023)

5.5 Rehospitalization & Mortality Reduction Trends (2023)

6. Competitive Landscape

6.1 List of Major Companies, By Region

6.2 Market Share Analysis, By Region

6.3 Service Benchmarking

6.3.1 Service specifications and features

6.3.2 Pricing

6.4 Strategic Initiatives

6.4.1 Marketing and promotional activities

6.4.2 Distribution and Supply Chain Strategies

6.4.3 Expansion plans and new Service launches

6.4.4 Strategic partnerships and collaborations

6.5 Technological Advancements

6.6 Market Positioning and Branding

7. Artificial Heart Market Segmentation, by Type  

    1. Chapter Overview

     7.2 LVADs

             7.2.1 LVADs Market Trends Analysis (2020-2032)

7.2.2 LVADs Market Size Estimates and Forecasts to 2032 (USD Billion) 

    7.3 Heart-Lung Machine

             7.3.1 Heart-Lung Machine Market Trends Analysis (2020-2032)

7.3.2 Heart-Lung Machine Market Size Estimates and Forecasts to 2032 (USD Billion)

    7.4 Total Artificial Heart

             7.4.1 Total Artificial Heart Market Trends Analysis (2020-2032)

7.4.2 Total Artificial Heart Market Size Estimates and Forecasts to 2032 (USD Billion)

8. Artificial Heart Market Segmentation, by Therapy

    1. Chapter Overview

     8.2 Bridge to Transplant

             8.2.1 Bridge to Transplant Market Trends Analysis (2020-2032)

8.2.2 Bridge to Transplant Market Size Estimates and Forecasts to 2032 (USD Billion)

    8.3 Destination Therapy

8.3.1 Destination Therapy Market Trends Analysis (2020-2032)

              8.3.2 Destination Therapy Market Size Estimates and Forecasts to 2032 (USD Billion)

8.4 Bridge to Decision

8.4.1 Bridge to Decision Market Trends Analysis (2020-2032)

              8.4.2 Bridge to Decision Market Size Estimates and Forecasts to 2032 (USD Billion)

8.5 Others

8.5.1 Others Market Trends Analysis (2020-2032)

              8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)

9. Regional Analysis

9.1 Chapter Overview

9.2 North America

9.2.1 Trends Analysis

9.2.2 North America Artificial Heart Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)

9.2.3 North America Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion) 

9.2.4 North America Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.2.5 USA

9.2.5.1 USA Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.2.5.2 USA Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.2.6 Canada

9.2.6.1 Canada Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.2.6.2 Canada Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.2.7 Mexico

9.2.7.1 Mexico Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.2.7.2 Mexico Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3 Europe

9.3.1 Eastern Europe

9.3.1.1 Trends Analysis

9.3.1.2 Eastern Europe Artificial Heart Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)

9.3.1.3 Eastern Europe Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion) 

9.3.1.4 Eastern Europe Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.1.5 Poland

9.3.1.5.1 Poland Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.3.1.5.2 Poland Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.1.6 Romania

9.3.1.6.1 Romania Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.3.1.6.2 Romania Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.1.7 Hungary

9.3.1.7.1 Hungary Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.3.1.7.2 Hungary Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.1.8 Turkey

9.3.1.8.1 Turkey Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.3.1.8.2 Turkey Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.1.9 Rest of Eastern Europe

9.3.1.9.1 Rest of Eastern Europe Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.3.1.9.2 Rest of Eastern Europe Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.2 Western Europe

9.3.2.1 Trends Analysis

9.3.2.2 Western Europe Artificial Heart Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)

9.3.2.3 Western Europe Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion) 

9.3.2.4 Western Europe Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.2.5 Germany

9.3.2.5.1 Germany Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.3.2.5.2 Germany Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.2.6 France

9.3.2.6.1 France Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.3.2.6.2 France Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.2.7 UK

9.3.2.7.1 UK Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.3.2.7.2 UK Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.2.8 Italy

9.3.2.8.1 Italy Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.3.2.8.2 Italy Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.2.9 Spain

9.3.2.9.1 Spain Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.3.2.9.2 Spain Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.2.10 Netherlands

9.3.2.10.1 Netherlands Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.3.2.10.2 Netherlands Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.2.11 Switzerland

9.3.2.11.1 Switzerland Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.3.2.11.2 Switzerland Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.2.12 Austria

9.3.2.12.1 Austria Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.3.2.12.2 Austria Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.3.2.13 Rest of Western Europe

9.3.2.13.1 Rest of Western Europe Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.3.2.13.2 Rest of Western Europe Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.4 Asia Pacific

9.4.1 Trends Analysis

9.4.2 Asia Pacific Artificial Heart Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)

9.4.3 Asia Pacific Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion) 

9.4.4 Asia Pacific Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.4.5 China

9.4.5.1 China Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.4.5.2 China Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.4.6 India

9.4.5.1 India Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.4.5.2 India Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.4.5 Japan

9.4.5.1 Japan Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.4.5.2 Japan Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.4.6 South Korea

9.4.6.1 South Korea Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.4.6.2 South Korea Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.4.7 Vietnam

9.4.7.1 Vietnam Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.2.7.2 Vietnam Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.4.8 Singapore

9.4.8.1 Singapore Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.4.8.2 Singapore Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.4.9 Australia

9.4.9.1 Australia Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.4.9.2 Australia Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.4.10 Rest of Asia Pacific

9.4.10.1 Rest of Asia Pacific Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.4.10.2 Rest of Asia Pacific Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.5 Middle East and Africa

9.5.1 Middle East

9.5.1.1 Trends Analysis

9.5.1.2 Middle East Artificial Heart Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)

9.5.1.3 Middle East Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion) 

9.5.1.4 Middle East Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.5.1.5 UAE

9.5.1.5.1 UAE Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.5.1.5.2 UAE Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.5.1.6 Egypt

9.5.1.6.1 Egypt Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.5.1.6.2 Egypt Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.5.1.7 Saudi Arabia

9.5.1.7.1 Saudi Arabia Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.5.1.7.2 Saudi Arabia Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.5.1.8 Qatar

9.5.1.8.1 Qatar Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.5.1.8.2 Qatar Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.5.1.9 Rest of Middle East

9.5.1.9.1 Rest of Middle East Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.5.1.9.2 Rest of Middle East Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.5.2 Africa

9.5.2.1 Trends Analysis

9.5.2.2 Africa Artificial Heart Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)

9.5.2.3 Africa Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion) 

9.5.2.4 Africa Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.5.2.5 South Africa

9.5.2.5.1 South Africa Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.5.2.5.2 South Africa Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.5.2.6 Nigeria

9.5.2.6.1 Nigeria Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.5.2.6.2 Nigeria Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.6 Latin America

9.6.1 Trends Analysis

9.6.2 Latin America Artificial Heart Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)

9.6.3 Latin America Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion) 

9.6.4 Latin America Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.6.5 Brazil

9.6.5.1 Brazil Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.6.5.2 Brazil Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.6.6 Argentina

9.6.6.1 Argentina Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.6.6.2 Argentina Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.6.7 Colombia

9.6.7.1 Colombia Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.6.7.2 Colombia Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

9.6.8 Rest of Latin America

9.6.8.1 Rest of Latin America Artificial Heart Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)

9.6.8.2 Rest of Latin America Artificial Heart Market Estimates and Forecasts, by Therapy (2020-2032) (USD Billion)

10. Company Profiles

10.1 SynCardia Systems, LLC

10.1.1 Company Overview

10.1.2 Financial

10.1.3 Products/ Services Offered

10.1.4 SWOT Analysis

10.2 CARMAT

10.2.1 Company Overview

10.2.2 Financial

10.2.3 Products/ Services Offered

10.2.4 SWOT Analysis

10.3 BiVACOR Inc.

10.3.1 Company Overview

10.3.2 Financial

10.3.3 Products/ Services Offered

10.3.4 SWOT Analysis

10.4 RealHeart

10.4.1 Company Overview

10.4.2 Financial

10.4.3 Products/ Services Offered

10.4.4 SWOT Analysis

10.5 Abbott

10.5.1 Company Overview

10.5.2 Financial

10.5.3 Products/ Services Offered

10.5.4 SWOT Analysis

10.6 ABIOMED (Johnson & Johnson Services Inc.)

              10.6.1 Company Overview

10.6.2 Financial

10.6.3 Products/ Services Offered

10.6.4 SWOT Analysis

10.7 Jarvik Heart, Inc.

10.7.1 Company Overview

10.7.2 Financial

10.7.3 Products/ Services Offered

10.7.4 SWOT Analysis

10.8 LivaNova PLC

10.8.1 Company Overview

10.8.2 Financial

10.8.3 Products/ Services Offered

10.8.4 SWOT Analysis

10.9 Getinge

10.9.1 Company Overview

10.9.2 Financial

10.9.3 Products/ Services Offered

10.9.4 SWOT Analysis

10.10 Terumo Corporation

10.10.1 Company Overview

10.10.2 Financial

10.10.3 Products/ Services Offered

10.10.4 SWOT Analysis

11. Use Cases and Best Practices

12. Conclusion